InMode (INMD) Operating Expenses (2018 - 2026)
InMode (INMD) posted quarterly Operating Expenses of $51.5 million for Q1 2026, up 13.7% year-on-year from $45.3 million in Q1 2025, and down 6.89% on a QoQ basis from $55.3 million in Q4 2025.
InMode (INMD) Operating Expenses (2018 - 2026) Analysis & Trends
InMode (INMD) has reported Operating Expenses for 9 consecutive years, with $51.5 million the latest figure, recorded in Q1 2026.
- Quarterly Operating Expenses rose 13.7% year-over-year to $51.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $211.8 million (up 3.82% YoY) and the FY2025 annual result came in at $205.6 million, up 0.51% from the prior year.
- Operating Expenses fell to $51.5 million in Q1 2026 per INMD's latest filing, from $55.3 million in the prior quarter.
- Over the last five years, Operating Expenses for INMD reached as high as $57.9 million in Q3 2024 and fell as low as $36.1 million in Q1 2022.
- A 5-year average of $50.6 million and a median of $51.4 million in 2025 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2022 — Operating Expenses surged 38.36% — and 2025, when it retreated 11.23%.
- Year by year, Operating Expenses stood at $52.7 million in 2022, then grew by 4.94% to $55.3 million in 2023, then retreated by 9.95% to $49.8 million in 2024, then gained by 11.12% to $55.3 million in 2025, then slipped by 6.89% to $51.5 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $51.5 million, $55.3 million, and $51.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.82 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 2.87 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 3.59 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 2.51 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 785.50 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 495.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -668.50 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 1.46 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | -47.00 Mn |
| 10 | InMode | 956,721.10 | -479.17 Mn | 61.55 Mn | 51.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 51.50 Mn |
| Dec 31, 2025 | 55.31 Mn |
| Sep 30, 2025 | 51.41 Mn |
| Jun 30, 2025 | 53.57 Mn |
| Mar 31, 2025 | 45.29 Mn |
| Dec 31, 2024 | 49.77 Mn |
| Sep 30, 2024 | 57.92 Mn |
| Jun 30, 2024 | 51.02 Mn |
| Mar 31, 2024 | 45.83 Mn |
| Dec 31, 2023 | 55.27 Mn |
| Sep 30, 2023 | 56.57 Mn |
| Jun 30, 2023 | 57.02 Mn |
| Mar 31, 2023 | 46.82 Mn |
| Dec 31, 2022 | 52.67 Mn |
| Sep 30, 2022 | 48.72 Mn |
| Jun 30, 2022 | 45.40 Mn |
| Mar 31, 2022 | 36.14 Mn |
| Dec 31, 2021 | 39.54 Mn |
| Sep 30, 2021 | 35.22 Mn |
| Jun 30, 2021 | 33.07 Mn |